Detalhe da pesquisa
1.
Piloting international production of rapid relative effectiveness assessments of pharmaceuticals.
Int J Technol Assess Health Care
; 30(5): 521-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25747562
2.
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
Nat Med
; 9(6): 729-35, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12766765
3.
Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.
J Infect Dis
; 202(8): 1265-72, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20812851
4.
Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection.
Microb Pathog
; 46(5): 235-42, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19486640
5.
Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
Comp Med
; 56(4): 272-8, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16941954
6.
High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.
Clin Infect Dis
; 40(10): 1500-7, 2005 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15844073
7.
Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.
AIDS
; 17(16): 2351-5, 2003 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-14571187
8.
New vaccines for the prevention of tuberculosis.
Clin Infect Dis
; 35(4): 465-74, 2002 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12145732
9.
Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.
PLoS One
; 6(7): e22074, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21799772
10.
Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.
Vaccine
; 28(48): 7652-8, 2010 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20875492
11.
Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response.
Microb Pathog
; 45(1): 25-9, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18456450
12.
Up-regulation of host cell genes during interferon-gamma-induced persistent Chlamydia pneumoniae infection in HL cells.
J Infect Dis
; 195(2): 212-9, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17191166
13.
Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.
J Infect Dis
; 195(1): 118-23, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17152015
14.
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.
Vaccine
; 24(21): 4554-61, 2006 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-16150517
15.
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
Vaccine
; 24(15): 2850-9, 2006 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-16434127
16.
Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
J Immunol
; 174(1): 449-55, 2005 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15611270
17.
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
J Immunol
; 175(9): 5675-80, 2005 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16237057
18.
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
Proc Natl Acad Sci U S A
; 102(13): 4836-41, 2005 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-15781866
19.
Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.
Vaccine
; 23(7): 857-64, 2005 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-15603885
20.
Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.
Clin Diagn Lab Immunol
; 10(3): 367-75, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12738633